Thank you very much! Your form has been received!
Oops! Something went wrong while submitting the form.
The long-term storage of sensitive biological samples requires more than just low-temperature technology. Validated processes, redundant systems and seamless monitoring are crucial. Consarctic develops holistic cryopreservation solutions for stem cells and cell therapies that meet the highest GMP requirements and offer maximum process reliability.
Cell therapy products are highly sensitive, valuable and regulatory demanding. Consarctic combines technological excellence, GMP know-how and decades of experience in the development of safe cryostorage solutions.
Successful cryopreservation begins long before the actual storage. Each process step must be precisely controlled and coordinated in order to avoid cell damage and comply with regulatory requirements.
The controlled freezing process prevents the formation of harmful ice crystals and ensures the structural integrity of the cells. After freezing, the cells are safely transferred to validated cryostorage systems for long-term storage of stem cells and cell therapies. Consarctic ensures that all transitions are seamless, documented and GMP-compliant.
Consarctic offers modular, scalable cryolysis solutions that can be flexibly adapted to growing production capacities and new therapeutic approaches. Whether research laboratory, biotech company or industrial cell therapy production - our systems are designed with the future in mind.
Cryostorage systems combine automated nitrogen supply, intelligent control and validated hardware to create an end-to-end GMP infrastructure. The result: reproducible processes, minimized operating costs and maximum safety for sensitive cell therapies.
Cell therapies are extremely sensitive to temperature deviations and process errors. A specialized infrastructure ensures that cell quality and regulatory compliance are guaranteed at all times.
Stable cryogenic temperatures, controlled freezing processes and continuous monitoring mean that cells can be stored for decades without any loss of quality.
An integrated solution reduces interfaces, minimizes sources of error and considerably simplifies validation, operation and maintenance.
Storage must be validated, documented, monitored and traceable. This includes qualified systems, alarm scenarios, emergency concepts and regular re-validation.
Redundant temperature and level sensors, real-time monitoring, automated alarms and audit-capable data storage are recommended.
Are you planning a new cryogenic infrastructure or would you like to expand existing systems in compliance with GMP? The experts at Consarctic will advise you individually - from the concept phase to the long-term operation of your cryopreservation solution for stem cells and cell therapies.